{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:08:43Z","timestamp":1790813323310,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This study aimed to investigate contrast-enhanced ultrasound (CEUS) and clinical features associated with early recurrence (ER) following surgical resection in patients with microvascular invasion (MVI)-negative hepatocellular carcinoma (HCC), and to establish a nomogram-based predictive model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 146 pathologically confirmed MVI-negative HCC patients were retrospectively enrolled between August 2021 and June 2024. Univariable and multivariable Cox regression analyses were performed based on CEUS and clinicopathologic variables to identify predictors and develop a nomogram for 2-year recurrence probability. Model performance and discriminative ability were evaluated using the concordance index (C-index), receiver operating characteristic curve, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Multivariable Cox analysis identified smooth morphology, intra-tumoral artery, glypican-3 expression, and albumin-bilirubin (ALBI) grade as independent predictors of ER (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). A nomogram incorporating CEUS and clinicopathologic variables was constructed and demonstrated a favorable C-index of 0.768 (95% confidence interval [CI], 0.711\u20130.817). The model showed strong discriminative ability, with an area under the curve of 0.870 (95% CI, 0.805\u20130.952), and DCA indicated good clinical utility. The derived risk score effectively stratified patients into high-risk and low-risk groups. Patients in the low-risk group exhibited significantly better prognosis compared with those in the high-risk group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This CEUS- and clinicopathology-based prognostic model accurately identifies high-risk MVI-negative HCC patients and may provide valuable information for optimizing surveillance and intervention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2174_25","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:39Z","timestamp":1779951639000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["CEUS features-based nomogram for predicting early recurrence (ER) of microvascular invasion-negative hepatocellular carcinoma"],"prefix":"10.4103","volume":"22","author":[{"given":"Qing","family":"Shu","sequence":"first","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizi","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound, The First Medical Centre, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260528","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.31289","article-title":"Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection","volume":"73","author":"Choi","year":"2021","journal-title":"Hepatology"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.31424","article-title":"Local and regional therapies for hepatocellular carcinoma","volume":"73","author":"Kloeckner","year":"2021","journal-title":"Hepatology"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"e934924","DOI":"10.12659\/AOT.934924","article-title":"Recurrence of hepatocellular carcinoma after liver transplantation: Risk factors and predictive models","volume":"27","author":"Stra\u015b","year":"2022","journal-title":"Ann Transplant"},{"key":"R7-20260528","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1038\/s41598-021-82058-x","article-title":"The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1007\/s00330-021-08502-8","article-title":"Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur Radiol"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.22.01142","article-title":"Postoperative adjuvant hepatic arterial infusion chemotherapy with FOLFOX in hepatocellular carcinoma with microvascular invasion: A multicenter, Phase III, randomized study","volume":"41","author":"Li","year":"2023","journal-title":"J Clin Oncol"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-019-07227-9","article-title":"Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma","volume":"26","author":"Erstad","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.4103\/jcrt.jcrt_203_24","article-title":"The ability of contrast-enhanced ultrasound with Sonazoid to differentiate endometrial carcinoma from benign endometrial lesions: A preliminary, prospective, and multicenter clinical study","volume":"20","author":"Li","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R12-20260528","doi-asserted-by":"crossref","first-page":"e240419","DOI":"10.1148\/rycan.240419","article-title":"Prediction of macrotrabecular-massive hepatocellular carcinoma and associated prognosis using contrast-enhanced US and clinical features","volume":"7","author":"Wu","year":"2025","journal-title":"Radiol Imaging Cancer"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"111007","DOI":"10.1016\/j.cellsig.2023.111007","article-title":"The role and mechanism of HIF-1a-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma","volume":"114","author":"Wang","year":"2024","journal-title":"Cell Signal"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms241310922","article-title":"Glypican-3 (GPC-3) structural analysis and cargo in serum small extracellular vesicles of hepatocellular carcinoma patients","volume":"24","author":"Mauro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4103\/jcrt.jcrt_614_25","article-title":"Prognostic value of alpha-fetoprotein and des-gamma-carboxyprothrombin in hepatocellular carcinoma treated with transarterial chemoembolization","volume":"21","author":"Liu","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"1142168","DOI":"10.3389\/fonc.2023.1142168","article-title":"Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma","volume":"13","author":"Wenpei","year":"2023","journal-title":"Front Oncol"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/cancers15030687","article-title":"Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma","volume":"15","author":"Cha","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R20-20260528","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00535-024-02202-y","article-title":"Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: A retrospective multi-center cohort study","volume":"60","author":"Zhang","year":"2025","journal-title":"J Gastroenterol"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"e11402","DOI":"10.1097\/MD.0000000000011402","article-title":"Preoperative computed tomography and serum a-fetoprotein to predict microvascular invasion in hepatocellular carcinoma","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.1038\/s41598-017-15491-6","article-title":"A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"R23-20260528","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1148\/rg.2021210009","article-title":"Pathologic, molecular, and prognostic radiologic features of hepatocellular carcinoma","volume":"41","author":"Fowler","year":"2021","journal-title":"Radiographics"},{"key":"R24-20260528","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2015150998","article-title":"Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?","volume":"279","author":"Renzulli","year":"2016","journal-title":"Radiology"},{"key":"R25-20260528","doi-asserted-by":"crossref","first-page":"900","DOI":"10.4103\/jcrt.jcrt_936_25","article-title":"Application of superresolution ultrasound imaging for assessing microvascular structure and hemodynamic changes in rabbit Vx2 models","volume":"21","author":"Chen","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R26-20260528","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/liv.15231","article-title":"Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI","volume":"42","author":"Jiang","year":"2022","journal-title":"Liver Int"},{"key":"R27-20260528","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1097\/JS9.0000000000001752","article-title":"Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study","volume":"110","author":"Jiang","year":"2024","journal-title":"Int J Surg"},{"key":"R28-20260528","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumor vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"key":"R29-20260528","doi-asserted-by":"crossref","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","article-title":"The roles of tumor-associated macrophages in tumor angiogenesis and metastasis","volume":"353","author":"Fu","year":"2020","journal-title":"Cell Immunol"},{"key":"R30-20260528","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumor angiogenesis and tumor immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"R31-20260528","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-1177-0530","article-title":"Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver-Update 2020-WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","volume":"41","author":"Dietrich","year":"2020","journal-title":"Ultraschall Med"},{"key":"R32-20260528","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-020-02462-1","article-title":"32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"1026245","DOI":"10.3389\/fonc.2023.1026245","article-title":"The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and 18F-FDG PET\/CT","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"e0216173","DOI":"10.1371\/journal.pone.0216173","article-title":"Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"R36-20260528","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jvir.2017.05.020","article-title":"Albumin-bilirubin and platelet-albumin-bilirubin grades accurately predict overall survival in high-risk patients undergoing conventional transarterial chemoembolization for hepatocellular carcinoma","volume":"28","author":"Hansmann","year":"2017","journal-title":"J Vasc Interv Radiol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2174_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:39:24Z","timestamp":1787845164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2174_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2174_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}